Aida F. Karamysheva
Moscow, MOW 115478, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Killing Glioblastoma Cells with Glycosylated Indolocarbazole-Based Derivative LCS1269: A Potential Crosstalk Between Micronuclei Formation and the Concurrent Induction of Apoptosis, Necroptosis, and Pyroptosis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 02, 2026
Targeting Topoisomerase I and DNA with LCS1269 Drives Glioblastoma Cell Death Despite ATM/Chk1/BRCA1/RAD51 Signaling Pathway Activation.
Journal: International journal of molecular sciences
Published: April 21, 2025
N-Glycoside of Indolo[2,3-a]pyrrolo[3,4-c]carbazole LCS1269 Exerts Anti-Glioblastoma Effects by G2 Cell Cycle Arrest and CDK1 Activity Modulation: Molecular Docking Studies, Biological Investigations, and ADMET Prediction.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 06, 2024
Clinical Relevance of Differential RARα and PPARβ/δ Expression in Myelodysplastic Syndromes.
Journal: In vivo (Athens, Greece)
Published: October 30, 2023
Evaluation of VEGF and VEGFR gene expression as prognostic markers in low and intermediate‑1 risk patients with myelodysplastic syndromes.
Journal: Oncology letters
Published: August 31, 2022
A novel glycosylated indolocarbazole derivative LCS1269 effectively inhibits growth of human cancer cells in vitro and in vivo through driving of both apoptosis and senescence by inducing of DNA damage and modulating of AKT/mTOR/S6K and ERK pathways.
Journal: Chemico-biological interactions
Published: March 14, 2022
Triterpenoids with modified A-ring as modulators of P-gp-dependent drug-resistance in cancer cells.
Journal: Chemico-biological interactions
Published: June 05, 2021
Analysis of VEGF-A/VEGFR1/VEGFR2 gene expression in patients with myelodysplastic syndrome
Journal: Terapevticheskii arkhiv
Published: August 03, 2017
Vascular endothelial growth factor receptor 3 is a novel marker differing CD138-positive and CD138-negative multiple myeloma cells.
Journal: British journal of haematology
Published: January 10, 2017
RARα mediates all-trans-retinoic acid-induced VEGF-C, VEGF-D, and VEGFR3 expression in lung cancer cells.
Journal: Cell biology international
Published: October 09, 2015
Gene expression of vascular endothelial growth factors and their receptors in different variants of the course of multiple myeloma
Journal: Terapevticheskii arkhiv
Published: October 22, 2013
Last Updated: 09/26/2026